Rom WN. Asbestosis, pleural fibrosis and lung cancer. In: Rom WN, Markowitz SB, eds. Environmental and occupational medicine 4th ed. Philadelphia: Lippincott Williams and Wilkins; 2007:298-316.
Begin R, Samet J, Shaikh RA. Asbestos. In: Harber P, Schenker MB, Balmes JR, eds. Occupational and environmental respiratory disease. St. Louis: Mosby-Year Book Inc; 1996:293-329.
Banks DE, Shi R, McLarty J, et al. American College of Chest Physicians consensus statement on the respiratory health effects of asbestos. Results of a Delphi study. Chest. 2009;135:1619-1627.
Markowitz SB, Levin SM, Miller A, et al. Asbestos, asbestosis, smoking, and lung cancer. New findings from the North American insulator cohort. Am J Respir Crit Care Med. 2013;188:90-96.
1. American Thoracic Society. Diagnosis and initial management of nonmalignant diseases related to asbestos. Am J Respir Crit Care Med. 2004;170:691-715.
2. Finnish Institute of Occupational Health. Asbestos, asbestosis and cancer: Helsinki criteria for diagnosis and attribution 2014. June 2014. http://www.ttl.fi/en/ (last accessed 25 October 2016).
3. National Institute for Occupational Safety and Health. Work-related lung disease surveillance system. http://wwwn.cdc.gov/ (last accessed 19 August 2016).
4. Rom WN. Asbestosis, pleural fibrosis and lung cancer. In: Rom WN, Markowitz SB, eds. Environmental and occupational medicine 4th ed. Philadelphia: Lippincott Williams and Wilkins; 2007:298-316.
5. Anderson HA, Lilis R, Daum SM, et al. Household-contact asbestos neoplastic risk. Ann NY Acad Sci. 1976;271:311-323.
6. LaDou J. The asbestos cancer epidemic. Environ Health Persp. 2004;112:285-290.
7. Begin R, Samet J, Shaikh RA. Asbestos. In: Harber P, Schenker MB, Balmes JR, eds. Occupational and environmental respiratory disease. St. Louis: Mosby-Year Book Inc; 1996:293-329.
8. Dupre JS, Mustard JF, Uffen RJ. Report of the Royal Commission on Matters of Health and Safety Arising from the Use of Asbestos in Ontario Vol I-III. Ontario Ministry of the Attorney General. Toronto, ON: Queen's Printer for Ontario;1984.
9. Egilman D, Fehnil C, Bohme SR. Exposing the myth of ABC "anything but chrysotile" a critique of the Canadian asbestos mining industry and McGill University chrysotile studies. Am J Ind Med. 2003;44:540-557.
10. Ashcroft T, Heppleson AG. The optical and electron microscopic determination of pulmonary asbestos fibre concentration and its relation to human pathological reaction. J Clin Pathol. 1973;26:224-234.
11. Suzuki Y, Kohyama N. Translocation of inhaled asbestos fibers from the lung to other tissue. Am J Ind Med. 1991;19:701-704.
12. Constantopoulos SH, Theodoracopoulos P, Dascalopoulos G, et al. Metsovo lung outside Metsovo. Endemic pleural calcifications in the ophiolite belts of Greece. Chest. 1991;99:1158-1161.
13. Peipins LA, Lewin M, Campolucci S, et al. Radiographic abnormalities and exposure to asbestos-contaminated vermiculite in the community of Libby Montana, USA. Environ Health Perspect. 2003;111:1753-1759.
14. Bégin R, Filion R, Ostiguy G. Emphysema in silica- and asbestos-exposed workers seeking compensation: a CT scan study. Chest. 1995;108:647-655.
15. Ohar J, Sterling DA, Bleeker E, et al. Changing patterns in asbestos-induced lung disease. Chest. 2004;125:744-753.
16. Kilburn KH, Warshaw RH. Airway obstruction in asbestos-exposed shipyard workers with and without irregular opacities. Respir Med. 1990;84:449-455.
17. DeVuyst P, Dumortier P, Moulin E, et al. Diagnostic value of asbestos bodies in bronchoalveolar lavage fluid. Am Rev Respir Dis. 1987;136:1219-1224.
18. deShazo RD, Daul CB, Morgan JE, et al. Immunological investigations in asbestos exposed workers. Chest. 1986;89(Suppl):162S-165S.
19. Rosenman KD, Reilly MJ. Asbestos-related x-ray changes in foundry workers. Am J Ind Med. 1998;34:197-201.
20. International Labour Office. Guidelines for the use of the ILO international classification of radiographs of pneumoconiosis. Occupational Safety and Health Series, No. 22 (rev 2000). Geneva: ILO; 2002.
21. Selikoff IJ, Seidman H. Asbestos-associated deaths among workers in the United States and Canada, 1967-1987. Ann NY Acad Sci. 1991;643:1-14.
22. Spruit MA, Singh SJ, Garvey C, et al. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med. 2013;188:e13-e64.
23. Dale MT, McKeough ZJ, Troosters T, et al. Exercise training to improve exercise capacity and quality of life in people with non-malignant dust-related respiratory diseases. Cochrane Database Syst Rev. 2015;(11):CD009385.
24. Dowman L, Hill CJ, Holland AE. Pulmonary rehabilitation for interstitial lung disease. Cochrane Database Syst Rev. 2014;(10):CD006322.
25. Alalawi R, Whelan T, Bajwa RS. Lung transplantation and interstitial lung disease. Curr Opin Pulm Med. 2005;11:461-466.
26. Castleman BI. Asbestos: medical and legal aspects. 5th edition. New York: Aspen; 2005.
27. Banks DE, Shi R, McLarty J, et al. American College of Chest Physicians consensus statement on the respiratory health effects of asbestos. Results of a Delphi study. Chest. 2009;135:1619-1627.
28. Markowitz SB, Levin SM, Miller A, et al. Asbestos, asbestosis, smoking, and lung cancer. New findings from the North American insulator cohort. Am J Respir Crit Care Med. 2013;188:90-96.
29. Homa DM, Garabrant DH, Gillespie BW. A meta-analysis of colorectal cancer and asbestos exposure. Am J Epidemiol. 1994; 139:1210-1222.
30. Goodman M, Morgan RW, Ray R, et al. Cancer in asbestos-exposed occupational cohorts: a meta-analysis. Cancer Causes Control. 1999;10:453-465.
31. Pass HI, Levin SM, Harbut MR, et al. Fibulin-3 as a blood and effusion biomarker for pleural mesothelioma. New Eng J Med. 2012;367:1417-1427.
32. Wender R, Fontham ETH, Barrera E, et al. American Cancer Society lung cancer screening guidelines. CA Cancer J Clin. 2013;63:106-117.
33. Druesne-Pecollo N, Latino-Martel P, Norat T, et al. Beta-carotene supplementation and cancer risk: a systematic review and metaanalysis of randomized controlled trials. Int J Cancer. 2010;127:172-184.
使用此内容应接受我们的免责声明。
BMJ临床实践的持续改进离不开您的帮助和反馈。如果您发现任何功能问题和内容错误,或您对BMJ临床实践有任何疑问或建议,请您扫描右侧二维码并根据页面指导填写您的反馈和联系信息*。一旦您的建议在我们核实后被采纳,您将会收到一份小礼品。
如果您有紧急问题需要我们帮助,请您联系我们。
邮箱:bmjchina.support@bmj.com
电话:+86 10 64100686-612
*您的联系信息仅会用于我们与您确认反馈信息和礼品事宜。
BMJ临床实践官方反馈平台